On 2025-08-07, Athira Pharma, Inc. (ATHA) announced earnings per share of $-1.80 for the fiscal quarter ending 2025-06-30, meeting the average analyst estimate of $-1.80.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-08-07 | 2025-06-30 | $-1.80 | $-1.80 |
| 2025-05-09 | 2025-03-31 | $-2.00 | $-2.30 |
| 2025-02-27 | 2024-12-31 | $-2.30 | $-3.90 |
| 2024-11-07 | 2024-09-30 | $-8.00 | $-7.50 |
| 2024-08-01 | 2024-06-30 | $-7.50 | $-7.00 |
| 2024-05-15 | 2024-03-31 | $-8.00 | $-6.90 |
| 2024-02-22 | 2023-12-31 | $-9.60 | $-7.10 |
| 2023-11-09 | 2023-09-30 | $-8.70 | $-8.70 |
| 2023-08-10 | 2023-06-30 | $-8.10 | $-7.80 |
| 2023-05-11 | 2023-03-31 | $-6.60 | $-7.30 |
| 2023-03-23 | 2022-12-31 | $-7.00 | $-7.90 |
| 2022-11-10 | 2022-09-30 | $-6.70 | $-5.30 |
| 2022-08-15 | 2022-06-30 | $-6.60 | $-6.50 |
| 2022-05-12 | 2022-03-31 | $-6.30 | $-5.60 |
| 2022-03-24 | 2021-12-31 | $-6.10 | $-3.70 |
| 2021-11-10 | 2021-09-30 | $-5.00 | $-4.20 |
| 2021-08-16 | 2021-06-30 | $-3.70 | $-3.80 |
| 2021-05-13 | 2021-03-31 | $-3.00 | $-2.50 |
| 2021-03-25 | 2020-12-31 | $-2.90 | $-2.40 |
| 2020-11-12 | 2020-09-30 | $-2.50 | $-11.20 |